Latest Headlines

2017 | 2016 | 2015 | 2014 | 2013 | 2012

March 2017

A new study proves how good "one-stop shop" contraceptive care is for women

A new study suggests that combining family planning services with other medical care can improve women’s health — just as the Trump administration prepares for dramatic cuts in health funding that could roll back these and other gains.

“One-stop shop” family planning more effective for women living with HIV

UCSF Bixby Center

Bixby Center researchers have released the first study to show that integrating HIV care and family planning s

Making birth control pills available OTC could benefit teens most

UCSF Bixby Center

Support for making birth control pills available over-the-counter (OTC) has been growing for years.

Diana Greene Foster wins Society of Family Planning mentor award

UCSF Bixby Center

Congratulations to UCSF Bixby Center member Diana Greene Foster, PhD on receiving the Society of Family Planning's 

Analyzing disparities in postpartum care and contraception

UCSF Bixby Center
A new study identifies disparities in the care and contraception that postpartum low-income women in California receive.

Access to most effective birth control could save $12 billion a year

Using data from a 2015 study on birth control access by Bixby researchers, the Brookings Institute and Child Trends produced a report estimating the impact and cost savings that would result from every woman having full access to the most effective contraceptive methods.

Shaping policy with science: Highlights from the Bixby symposium

UCSF Bixby Center
On March 2, the one-year anniversary of the Supreme Court hearing Whole Woman’s Health v. Hellerstedt, the Bixby Center and BIRCWH convened a symposium focused on science’s role in shaping policy.

New tool brings shared decision-making to contraceptive counseling

UCSF Bixby Center
Nearly half of pregnancies in the U.S. are unintended, and many result from people failing to use contraception correctly or consistently. One way to improve contraceptive use is to help women select contraceptive methods that better accommodate their personal preferences.

February 2017

A call to end the excessive regulation of mifepristone

UCSF Bixby Center
In a recent New England Journal of Medicine commentary, a group of experts including the Bixby Center’s Dan Grossman called on the FDA to eliminate the FDA's excessive regulation of the medication abortion drug mifepristone.

Sixteen years of overregulation: Time to unburden Mifeprex

The New England Journal of Medicine
A group of experts, including Dan Grossman, director of ANSIRH and Bixby Center member, calls for an end to the FDA's overregulation of Mifeprex (mifepristone), a drug commonly used in medication abortions.